ASCO 2026: Latest updates in mRCC
Dr Locke speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about the ZUMA-1 trail for large B-cell lymphoma.
He goes into detail about the trial design and results so far, suggesting what this means for the future of the study and the outcomes for patients.
ASCO 2026: Latest updates in mRCC
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
Choosing 1st line TKI Wisely in patients with CML
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus